Cargando…

Immune Checkpoint Inhibition and the Prevalence of Autoimmune Disorders Among Patients With Lung and Renal Cancer

PURPOSE: Immune checkpoint inhibition reactivates the immune response against cancer cells in multiple tissue types and has been shown to induce durable responses. However, for patients with autoimmune disorders, their conditions can worsen with this reactivation. We sought to identify, among patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Refai, Sherif M, Brown, Joshua D, Black, Esther P, Talbert, Jeffery C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459511/ https://www.ncbi.nlm.nih.gov/pubmed/28615920 http://dx.doi.org/10.1177/1176935117712520

Ejemplares similares

The Prevalence and Predictors of Low-Cost Generic Program Use in the Pediatric Population
por: Pauly, Nathan James, et al.
Publicado: (2015)

The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
por: Brown, Joshua D., et al.
Publicado: (2016)

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
por: Coureau, Michelle, et al.
Publicado: (2020)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
por: Paluch, Christopher, et al.
Publicado: (2018)

Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer
por: Bidnur, S., et al.
Publicado: (2016)

Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes
por: Gámez-Díaz, Laura, et al.
Publicado: (2021)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)

Immune-related endocrine disorders in novel immune checkpoint inhibition therapy
por: Min, Le
Publicado: (2016)

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
por: Adashek, Jacob J., et al.
Publicado: (2018)

Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data
por: Pauly, Nathan J., et al.
Publicado: (2016)

Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis
por: Zhang, Amy L., et al.
Publicado: (2021)

A Case of Immune Checkpoint Inhibitor Induced Autoimmune Diabetes
por: Thambuluru, Sirisha Reddy
Publicado: (2021)

Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors
por: Duong, Sophie L., et al.
Publicado: (2022)

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
por: Maeda, Osamu
Publicado: (2023)

Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1
por: Kong, Yi-chi M., et al.
Publicado: (2014)

Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
por: Gao, Catherine A., et al.
Publicado: (2019)

Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer
por: Wills, Beatriz, et al.
Publicado: (2018)

TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
por: Benoot, Thomas, et al.
Publicado: (2021)

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer
por: Principe, Daniel R., et al.
Publicado: (2021)

Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
por: Leone, Gian Marco, et al.
Publicado: (2023)

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
por: Brown, Joshua D., et al.
Publicado: (2016)

Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures
por: Pauly, Nathan J., et al.
Publicado: (2017)

Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition
por: Sarkis, J., et al.
Publicado: (2021)

Immune checkpoint inhibitors in renal cell carcinoma
por: Ross, Kirsty, et al.
Publicado: (2017)

Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease
por: Macek Jilkova, Zuzana, et al.
Publicado: (2021)

The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies
por: Brom, Victoria C., et al.
Publicado: (2022)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
por: Zhai, Yujia, et al.
Publicado: (2021)

Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases
por: Gerasimova, Elena V., et al.
Publicado: (2022)

Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection
por: Zheng, Meijun, et al.
Publicado: (2023)

Non-retrieval of inferior vena cava filters as a patient safety concern: evaluation of a new process improvement project to increase retrieval rates in a vascular and interventional radiology clinic
por: Brown, Joshua, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
por: Herrmann, Sandra M., et al.
Publicado: (2020)

Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric Cohort
por: Brown, Joshua D., et al.
Publicado: (2015)

Neurosarcoidosis following Immune Checkpoint Inhibition
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)

Immune Checkpoint Inhibition in Hodgkin Lymphoma
por: Moy, Ryan H., et al.
Publicado: (2018)

Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer
por: Khan, Zia, et al.
Publicado: (2020)

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease
por: Tang, Hui, et al.
Publicado: (2021)

NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
por: Zhang, Yiwen, et al.
Publicado: (2021)

Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease
por: Alexander, Swetha, et al.
Publicado: (2021)

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
por: Horiguchi, Haruki, et al.
Publicado: (2023)

Editorial: Immune checkpoint inhibitors in renal cell carcinoma
por: Tykodi, Scott S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9oa2fekf1eag4g89ub2gjs6901